← Back to Clinical Trials
Recruiting NCT07233798

NCT07233798 Presence of Dural Pulsation in Patients Diagnosed With Lumbar Spinal Stenosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07233798
Status Recruiting
Phase
Sponsor Marmara University
Condition Lumbar Spinal Stenosis
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-12-07
Primary Completion 2026-12-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 85 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-12-07 with a primary completion date of 2026-12-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Lumbar spinal stenosis is defined as the narrowing of the spinal canal resulting from degenerative changes in the spinal joints, intervertebral discs, and the ligamentum flavum. Pressure fluctuations within the cerebral and spinal vascular systems lead to the formation of pulsations. The periodic occurrence of these pulsations in the dura mater is referred to as spinal dural pulsation.The vibratory movements of the dura mater have been interpreted as an indicator that the spinal cord is freely mobile within the subarachnoid space and not subjected to any external compression.This study aims to investigate whether the presence of dural pulsation is associated with clinical and radiological parameters in patients diagnosed with lumbar spinal stenosis

Eligibility Criteria

Inclusion criteria * Aged between 18 and 85 years * Patients experiencing low back and/or leg pain attributable to lumbar spinal stenosis * Presence of lumbar spinal stenosis at least at one level consistent with clinical symptoms on lumbar MRI * Willingness to participate in the study Exclusion criteria * Body Mass Index (BMI) ≥ 35 kg/m² * Patients with radiculopathy due to lumbar disc herniation * Patients with axial low back pain caused by facet syndrome, sacroiliac dysfunction, or discogenic pain * History of lumbar spine surgery * Individuals with mental retardation * Patients with major psychiatric comorbidities * Patients with congenital spinal anomalies * Inflammatory rheumatic diseases characterized by osteophyte formation and ligament calcification, such as ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis (DISH) * Pregnancy * Patients with heart failure

Contact & Investigator

Central Contact

Fatma B Akdağ, Research Assistant

✉ fatma.betul820@gmail.com

📞 +90 537 452 96 60

Principal Investigator

Fatma B Akdağ, Research Assistant

PRINCIPAL INVESTIGATOR

Marmara University Faculty of Medicine ,Marmara University, Department of Physical Medicine and Rehabilitation

Frequently Asked Questions

Who can join the NCT07233798 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Lumbar Spinal Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07233798 currently recruiting?

Yes, NCT07233798 is actively recruiting participants. Contact the research team at fatma.betul820@gmail.com for enrollment information.

Where is the NCT07233798 trial being conducted?

This trial is being conducted at Pendik, Turkey (Türkiye).

Who is sponsoring the NCT07233798 clinical trial?

NCT07233798 is sponsored by Marmara University. The principal investigator is Fatma B Akdağ, Research Assistant at Marmara University Faculty of Medicine ,Marmara University, Department of Physical Medicine and Rehabilitation. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology